Quick Answer
Apyx Medical Corp reported Net Income Loss of -$11.21 million for the year ending 2025.
- Apyx Medical Corp showed an increase of +52.2% in Net Income Loss from 2024 to 2025.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: -$7.0 thousand | Q4 2012: $285.0 thousand | Q1 2013: -$409.0 thousand | Q2 2013: -$1.12 million | Q3 2013: -$341.0 thousand | Q4 2013: -$5.13 million | Q1 2014: -$9.81 million | Q2 2014: $29.0 thousand | Q3 2014: -$2.98 million | Q4 2014: -$5.45 million | Q1 2015: -$876.0 thousand | Q2 2015: -$1.50 million | Q3 2015: -$1.59 million | Q4 2015: -$1.41 million | Q1 2016: -$1.94 million | Q2 2016: -$519.0 thousand | Q3 2016: -$965.0 thousand | Q1 2017: -$1.69 million | Q2 2017: -$1.31 million | Q3 2017: -$2.94 million | Q1 2018: -$2.79 million | Q2 2018: -$2.94 million | Q3 2018: $68.47 million | Q1 2019: -$4.68 million | Q2 2019: -$4.34 million | Q3 2019: -$4.37 million | Q1 2020: -$1.95 million | Q2 2020: -$4.69 million | Q3 2020: -$3.73 million | Q1 2021: -$4.90 million | Q2 2021: -$4.05 million | Q3 2021: -$4.22 million | Q1 2022: -$5.95 million | Q2 2022: -$5.43 million | Q3 2022: -$5.76 million | Q1 2023: -$3.48 million | Q2 2023: -$994.0 thousand | Q3 2023: -$4.63 million | Q1 2024: -$7.58 million | Q2 2024: -$6.56 million | Q3 2024: -$4.70 million | Q1 2025: -$4.15 million | Q2 2025: -$3.78 million | Q3 2025: -$1.98 million.
- Over the full 17 years of available data (2009 to 2025), Apyx Medical Corp's Net Income Loss has declined by 1,981.0%.
- Historical annual values: Fiscal year 2025: -$11.21 million | Fiscal year 2024: -$23.46 million | Fiscal year 2023: -$18.71 million | Fiscal year 2022: -$23.18 million | Fiscal year 2021: -$15.17 million | Fiscal year 2020: -$11.90 million | Fiscal year 2019: -$19.71 million | Fiscal year 2018: $62.72 million | Fiscal year 2017: -$5.06 million | Fiscal year 2016: -$11.55 million | Fiscal year 2015: -$5.37 million | Fiscal year 2014: -$17.28 million | Fiscal year 2013: -$4.34 million | Fiscal year 2012: $617.0 thousand | Fiscal year 2011: $109.0 thousand | Fiscal year 2010: -$1.54 million | Fiscal year 2009: $596.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: